Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
5m
Eli Lilly and Novo Nordisk’s obesity moat just got stronger
The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...
35m
Weight loss drugs Wegovy and Zepbound strain budgets amid skyrocketing copays
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
5-year extension w/ Dodgers
Bryar found dead at 44
Issues holiday scam warning
Florida sheriff to lead DEA
Outage at Philly airport
Ukraine seeks NATO invite
Arctic blast in US
State of emergency in NY
Departs for Pacific visit
Canadian media outlets sue
Former Hartford mayor dies
Tapped as FBI director
$28M Thanksgiving feast
Chiefs clinch playoff berth
Returns to Stanford as GM
Trump warns BRICS nations
Trudeau meets with Trump
Launches bid for DNC chair
To end cabin service earlier
Teen killed by stray bullet
Little Rock mall shooting
Cancels show due to injury
Bears fire coach Eberflus
Joins editorial board
Adani on US indictment
FIFA hosting bid report
Police: Man shot, killed
US Ambassador to France pick
Arms sale to Taiwan OK'd
Israeli strike in Gaza
Related topics
Joe Biden
Medicare
Wegovy
drugs
Amgen
Feedback